NCT04498858: TOBAFREE-DP

To Promote Tobacco Free Life in the Dental Practice in France

Completed Last updated 10 November 2021

What this trial tests

trial testing Patient interview in Tobacco Cessation in 139 participants. Completed in 13 September 2021.

Timeline

14 April 2021

Primary endpoint
13 September 2021

13 September 2021

Quick facts

Lead sponsor	University Hospital, Bordeaux
Status	Completed
Study type	OBSERVATIONAL
Enrollment	139
Start date	14 April 2021
Primary completion	13 September 2021
Estimated completion	13 September 2021
Sites	1 location across France

Drugs / interventions tested

• Patient interview

Conditions studied

• Tobacco Cessation — all drugs for Tobacco Cessation →
• Dental Practice — all drugs for Dental Practice →

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Tobacco Cessation or Dental Practice. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In France, 34% of the adult population is smoking every day. The links between smoking and the development of several chronic disorders is well established and smoking is directly implicated in most of the oral diseases such as cancers of the oral cavity. Thus, dentists have access to an area of the body that is actively affected and this gives them a central role in dispensing advice and support regarding smoking cessation.

Dentists often cite issues such as lack of time or education as a reason for why they do not offer support for smoking cessation. A brief intervention can increase smoking cessation by 30 to 100% (ie 1-3% in absolute value). The "5A" approach integrates and extends the brief intervention. It consists in Asking about smoking status, Advising smokers of the benefit of stopping, Assessing motivation to quit, Assisting smokers in their quit attempt, Arranging follow-up with stop-smoking services. For practitioners who do not have enough time, a "3A" approach might be acceptable (Ask, Advice and Act) by providing details of local stop smoking services and/or prescribing nicotine replacement therapy (NRT). This very brief advice can be delivered in less than one minute.

To investigators knowledge, the role of dentists in the French national tobacco-free program is not yet documented in France while since 2016, dentists can prescribe NRT with some products taken in charge by the French health insurance.

An intervention taking part in the continuing professional development will be developed so the dentists fell legitimate, motivated and competent to talk with their patients about their tobacco consumption and to assist them in their smoking cessation process. This intervention based on the 5/3A approach and prescription of NRT will include a specific training and provision of management kit, with communication tools and network for appropriate references.

Investigators hypothesize that 5/3A approach is feasible with adequate intervention in dental practices in France (dentists apply the approach to 90% of their patients) and that the format, the conditions, the barriers and the lever actions of its implementation are known.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.